Inventiva to Present at the J.P. Morgan Healthcare Conference in January
The biopharmaceutical company Inventiva announced that its CEO, Andrew Obenshain, will speak at the 44th annual J.P. Morgan Healthcare Conference, which will be held in San Francisco in mid-January.
Presentation Details
According to the company's press release, Andrew Obenshain will provide an overview of the company on Thursday, January 15, 2026, from 9:00 AM to 9:40 AM Pacific Time. The presentation will take place at the Westin St. Francis Hotel in San Francisco, California. The session will be broadcast live and available for replay on the company's website at https://inventivapharma.com/fr/investisseurs/presentations/. The J.P. Morgan Healthcare Conference, running from January 12 to January 15, 2026, is a major event in the biopharmaceutical sector.
Additional Meetings
In addition to the official presentation, Inventiva's management team will participate in bilateral meetings with investors, the company states. These individual meetings are scheduled for Wednesday, January 14, 2026, the day before the public presentation. These meetings typically allow executives to discuss in detail the company's strategy and development programs with institutional investors.
Research Focus
According to the company, Inventiva focuses on the development of orally administered small molecules for the treatment of steatohepatitis associated with metabolic dysfunction, also known as MASH. The company is currently evaluating Lanifibranor in a pivotal Phase 3 clinical study for the treatment of adult patients with this chronic liver disease. Inventiva is listed on compartment B of the regulated market of Euronext Paris and on the Nasdaq Global Market in the United States under the symbol IVA.
